Document is current
Any future updates will be listed below
-
Authors
Jeryczynski, Georg
Krall, Christoph
Pasalic, Sabina
Huber, Dominikus
Cacioppo, Filippo
Bartsch, Rupert
Fuereder, Thorsten
Laggner, Anton
Preusser, Matthias
Minichsdorfer, Christoph
-
Funding
Funding for this research was provided by:
Medical University of Vienna
- License Information
-
More Information
Article History
Received: 29 April 2024
Accepted: 3 October 2024
First Online: 16 October 2024
Declarations
:
: The retrospective database on which the study was based was approved by the ethics committee of the Medical University of Vienna (1860/20171860/2017). Due to the retrospective nature of the study, no informed consent of the individual patients is necessary according to local regulations.
: MP has received honoraria for lectures, consultation or advisory board participation from the following for-profit companies: Bayer, Bristol-Myers Squibb, Novartis, Gerson Lehrman Group (GLG), CMC Contrast, GlaxoSmithKline, Mundipharma, Roche, BMJ Journals, MedMedia, Astra Zeneca, AbbVie, Lilly, Medahead, Daiichi Sankyo, Sanofi, Merck Sharp & Dome, Tocagen, Adastra, Gan & Lee Pharmaceuticals, Janssen, Servier, Miltenyi, Böhringer-Ingelheim, Telix, Medscape. The other authors have no relevant financial or non-financial interests to disclose.The other authors have no relevant financial or non-financial interests to disclose.
